Perspectives on the burden of drug-resistant epilepsy and treatment priorities: Findings from a multistakeholder survey.
2026-03-27, Epilepsia open (10.1002/epi4.70226) (online)Simona Lattanzi, Bettina Schmitz, Nuno Canas, John Paul Leach, Caroline Benoist, Daniela Pierucci, and Elena Álvarez-Barón (?)
Drug-resistant epilepsy (DRE) imposes a significant burden on patients and their caregivers. This study aimed to explore the concerns and perceptions of healthcare providers (HCPs), patients, and caregivers regarding the burden of disease and quality of life (QoL) in patients with DRE.
This article has not yet been included in any curations.



Comments
There are no comments on this article yet.
You need to login or register to comment.